Fernando Vieira

Person

Boston, MA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Inhibition of dipeptide repeat proteins
- Patent number 11,857,534
- Issue date Jan 2, 2024
- ALS Therapy Development Institute
- Fernando G. Vieira
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-CD40L antibodies and methods for treating CD40L-related diseas...
- Patent number 11,692,040
- Issue date Jul 4, 2023
- ALS Therapy Development Institute
- John M. Lincecum
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Copper complexes for treatment of neurodegenerative disorders
- Patent number 11,660,324
- Issue date May 30, 2023
- ALS Therapy Development Institute
- Steven Perrin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Inhibition of dipeptide repeat proteins
- Patent number 11,607,402
- Issue date Mar 21, 2023
- ALS Therapy Development Institute
- Fernando G. Vieira
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-CD40L antibodies
- Patent number 11,014,990
- Issue date May 25, 2021
- ALS Therapy Development Institute
- John M. Lincecum
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of treating a CD40L associated disease or disorder by admin...
- Patent number 10,683,356
- Issue date Jun 16, 2020
- ALS Therapy Development Institute
- John M. Lincecum
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-CD40L antibodies
- Patent number 10,106,618
- Issue date Oct 23, 2018
- ALS Therapy Development Institute
- John M. Lincecum
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method for the treatment of neurodegenerative diseases
- Patent number 9,044,459
- Issue date Jun 2, 2015
- ALS Therapy Development Institute
- Steven Perrin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Targeting of T-lymphocytes to treat amyotrophic lateral sclerosis
- Patent number 8,946,301
- Issue date Feb 3, 2015
- ALS Therapy Development Institute
- Steven Perrin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Targeting of CD8+ T-lymphocytes to treat neurodegenerative diseases
- Patent number 8,673,308
- Issue date Mar 18, 2014
- ALS Therapy Development Institute
- Steven Perrin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method for the treatment of neurodegenerative diseases
- Patent number 8,435,514
- Issue date May 7, 2013
- ALS Therapy Development Institute
- Steven Perrin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
INHIBITION OF DIPEPTIDE REPEAT PROTEINS
- Publication number 20240261260
- Publication date Aug 8, 2024
- ALS Therapy Develpment Institute
- Fernando G. VIEIRA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-CD40L ANTIBODIES AND METHODS FOR TREATING CD40L-RELATED DISEAS...
- Publication number 20240043549
- Publication date Feb 8, 2024
- ALS Therapy Development Institute
- John M. Lincecum
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COPPER COMPLEXES FOR TREATMENT OF NEURODEGENERATIVE DISORDERS
- Publication number 20240016879
- Publication date Jan 18, 2024
- ALS Therapy Development Institute
- Steven Perrin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITION OF DIPEPTIDE REPEAT PROTEINS
- Publication number 20220142974
- Publication date May 12, 2022
- ALS Therapy Development Institute
- Fernando G. VIEIRA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-CD40L ANTIBODIES AND METHODS FOR TREATING CD40L-RELATED DISEAS...
- Publication number 20210269538
- Publication date Sep 2, 2021
- ALS Therapy Development Institute
- John M. Lincecum
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COPPER COMPLEXES FOR TREATMENT OF NEURODEGENERATIVE DISORDERS
- Publication number 20210038676
- Publication date Feb 11, 2021
- ALS Therapy Development Institute
- Steven Perrin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITION OF DIPEPTIDE REPEAT PROTEINS
- Publication number 20200405689
- Publication date Dec 31, 2020
- ALS Therapy Development Institute
- Fernando G. VIEIRA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-CD40L ANTIBODIES AND METHODS FOR TREATING CD40L-RELATED DISEAS...
- Publication number 20200277391
- Publication date Sep 3, 2020
- ALS Therapy Development Institute
- John M. Lincecum
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-CD40L ANTIBODIES AND METHODS FOR TREATING CD40L-RELATED DISEAS...
- Publication number 20190092868
- Publication date Mar 28, 2019
- ALS Therapy Development Institute
- John M. Lincecum
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-CD40L ANTIBODIES AND METHODS FOR TREATING CD40L-RELATED DISEAS...
- Publication number 20170342158
- Publication date Nov 30, 2017
- ALS Therapy Development Institute
- John M. Lincecum
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Method for the Treatment of Neurodegenerative Diseases
- Publication number 20130295092
- Publication date Nov 7, 2013
- Steven Perrin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TARGETING OF T-LYMPHOCYTES TO TREAT AMYOTROPHIC LATERAL SCLEROSIS
- Publication number 20130150454
- Publication date Jun 13, 2013
- ALS Therapy Development Institute
- Steven Perrin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TARGETING OF CD8+ T-LYMPHOCYTES TO TREAT NEURODEGENERATIVE DISEASES
- Publication number 20120237505
- Publication date Sep 20, 2012
- ALS Therapy Development Institute
- Steven Perrin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Method for the Treatment of Neurodegenerative Diseases
- Publication number 20110293612
- Publication date Dec 1, 2011
- ALS Therapy Development Institute
- Steven Perrin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Fernando Vieira

Person

Patents Grantslast 30 patents

Inhibition of dipeptide repeat proteins

Anti-CD40L antibodies and methods for treating CD40L-related diseas...

Copper complexes for treatment of neurodegenerative disorders

Inhibition of dipeptide repeat proteins

Anti-CD40L antibodies

Methods of treating a CD40L associated disease or disorder by admin...

Anti-CD40L antibodies

Method for the treatment of neurodegenerative diseases

Targeting of T-lymphocytes to treat amyotrophic lateral sclerosis

Targeting of CD8+ T-lymphocytes to treat neurodegenerative diseases

Method for the treatment of neurodegenerative diseases

Patents Applicationslast 30 patents

INHIBITION OF DIPEPTIDE REPEAT PROTEINS

ANTI-CD40L ANTIBODIES AND METHODS FOR TREATING CD40L-RELATED DISEAS...

COPPER COMPLEXES FOR TREATMENT OF NEURODEGENERATIVE DISORDERS

INHIBITION OF DIPEPTIDE REPEAT PROTEINS

ANTI-CD40L ANTIBODIES AND METHODS FOR TREATING CD40L-RELATED DISEAS...

COPPER COMPLEXES FOR TREATMENT OF NEURODEGENERATIVE DISORDERS

INHIBITION OF DIPEPTIDE REPEAT PROTEINS

ANTI-CD40L ANTIBODIES AND METHODS FOR TREATING CD40L-RELATED DISEAS...

ANTI-CD40L ANTIBODIES AND METHODS FOR TREATING CD40L-RELATED DISEAS...

ANTI-CD40L ANTIBODIES AND METHODS FOR TREATING CD40L-RELATED DISEAS...

Method for the Treatment of Neurodegenerative Diseases

TARGETING OF T-LYMPHOCYTES TO TREAT AMYOTROPHIC LATERAL SCLEROSIS

TARGETING OF CD8+ T-LYMPHOCYTES TO TREAT NEURODEGENERATIVE DISEASES

Method for the Treatment of Neurodegenerative Diseases